the Innovation Research Group in Colleges and Universities Program of Chongqing Municipal Education Commission(CXQT20012);the 2018 Postgraduate Tutor Team Construction Project of Chongqing(dstd201807);the Project of Science and Technology Research of Chongqing Education Commission(KJQN201800431)
Xu LIU, Xiaoli LI, Duanfang ZHOU, et al. Serum- and glucocorticoid-regulated kinase 3 promotes proliferation and inhibits apoptosis of ER+ breast cancer cells[J]. Journal of Third Military Medical University, 2021, 43(22): 2414-2422.
DOI:
Xu LIU, Xiaoli LI, Duanfang ZHOU, et al. Serum- and glucocorticoid-regulated kinase 3 promotes proliferation and inhibits apoptosis of ER+ breast cancer cells[J]. Journal of Third Military Medical University, 2021, 43(22): 2414-2422. DOI: 10.16016/j.1000-5404.202105155.
Serum- and glucocorticoid-regulated kinase 3 promotes proliferation and inhibits apoptosis of ER+ breast cancer cells
To investigate the effects of serum- and glucocorticoid-regulated kinase 3 (SGK3) on the proliferation and apoptosis of ER positive breast cancer cell lines MCF-7 and T47D.
Methods
2
Gene expression profile interactive analysis (GEPIA) was used to analyze SGK3 expression levels in BRCA (breast cancer tissue) and normal tissue in the cancer public database
the Cancer Genome Atlas (TCGA) database
and survival analysis was performed based on SGK3 levels in the BRCA patients in the TCGA database. After inducement of SGK3 overexpression in SGK3-inducible breast cancer cell lines MCF-7-Tet-On-SGK3 and T47D-Tet-On-SGK3
MTT assay was used to detect the effect of SGK3 overexpression on cell proliferation. Flow cytometry and Annexin V-FITC apoptosis detection kit were employed to detect the effect of SGK3 overexpression on cell apoptosis. Western blotting was applied to measure the changes of apoptosis-related protein molecules. After SGK3 was knocked down with SGK3 specific small interference RNA
MTT assay was adopted to detect the effect of SGK3 knockdown on the proliferation of MCF-7 cells
flow cytometry for cell apoptosis
and Western blotting for the molecular changes of apoptosis-related proteins.
Results
2
The TCGA database had a total of 1 084 BRCA samples and 492 breast control samples. Compared with the control breast tissue
the expression of SGK3 was significantly higher in BRCA. The GEPIA survival curve analysis showed that the expression level of SGK3 was negatively correlated with the overall survival (OS) and disease-free survival (DFS) of BRCA patients. In MCF-7-Tet-On-SGK3 and T47D-Tet-On-SGK3 cells
inducing SGK3 expression promoted cell proliferation and reduced the apoptosis. At molecular level
SGK3 overexpression down-regulated the expression of apoptotic proteins Bax and cleaved-PARP
and up-regulated the level of anti-apoptotic protein Bcl-2. SGK3 knockdown in MCF-7 and T47D cells inhibited cell proliferation and increased cell apoptosis. At the molecular level
knocking SGK3 down increased Bax protein level
reduced Bcl-2 level and up-regulated cleaved-PARP.
Conclusion
2
In ER
+
breast cancer
cells
SGK3 promotes cell proliferation and reduces apoptosis. Its high expression may be associated with poor prognosis in breast cancer patients.
关键词
Keywords
references
SIEGELR L, MILLER K D, JEMAL A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30. DOI: 10.3322/caac.21590.
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1): 7-34. DOI: 10.3322/caac.21551.
WAKSA G, WINER E P. Breast cancer treatment: a review[J]. JAMA, 2019, 321(3): 288-300. DOI: 10.1001/jama.2018.19323.
HANKERA B, SUDHAN D R, ARTEAGA C L. Overcoming endocrine resistance in breast cancer[J]. Cancer Cell, 2020, 37(4): 496-513. DOI: 10.1016/j.ccell.2020.03.009.
VASUDEVANK M, BARBIE D A, DAVIES M A, et al . AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer[J ] . Cancer Cell, 2009, 16(1): 21-32. DOI: 10.1016/j.ccr.2009.04.012.
CHIM N, GUO S T, WILMOTT J S, et al . INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas[J ] . Oncotarget, 2015, 6(37): 39891-39907. DOI: 10.18632/oncotarget.5359.
FRUMAND A, CHIU H, HOPKINS B D, et al . The PI3K pathway in human disease[J ] . Cell, 2017, 170(4): 605-635. DOI: 10.1016/j.cell.2017.07.029.
DI CRISTOFANO A. SGK1: the dark side of PI3K signaling[J]. Curr Top Dev Biol, 2017, 123: 49-71. DOI: 10.1016/bs.ctdb.2016.11.006.
TANG Z, LI C, KANG B, et al . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses[J ] . Nucleic Acids Res, 2017, 45(w1): W98-W102. DOI: 10.1093/nar/gkx247.
BRUHN M A, PEARSON R B, HANNAN R D, et al . AKT-independent PI 3 -K signaling in cancer—emerging role for SGK3[J ] . Cancer Manag Res, 2013, 5: 281-292. DOI: 10.2147/CMAR.S35178..
BRUHNM A, PEARSON R B, HANNAN R D, et al . Second AKT: the rise of SGK in cancer signalling[J ] . Growth Factors, 2010, 28(6): 394-408. DOI: 10.3109/08977194.2010.518616.
SCORTEGAGNA M, LAU E, ZHANG T W, et al . PDK1 and SGK3 contribute to the growth of BRAF-mutant melanomas and are potential therapeutic targets[J ] . Cancer Res, 2015, 75(7): 1399-1412. DOI: 10.1158/0008-5472.can-14-2785.
LONG X X, WEN F, CHEN Q, et al . Effect of TRIM31 gene silencing on the proliferation and apoptosis of U266 cells and its mechanism[J ] . J Exp Hematol, 2021, 29(3): 805-811. DOI: 10.19746/j.cnki.issn1009-2137.2021.03.024.
XU X B, LAI Y Y, HUA Z C. Apoptosis and apoptotic body: disease message and therapeutic target potentials[J]. Biosci Rep, 2019, 39(1): BSR20180992. DOI: 10.1042/BSR20180992.